Modified protein kinase a-specific oligonucleotides and methods of their use

摘要

The present invention relates to pharmaceutical compositions and methods for inhibiting the proliferation of cancer cells or treating cancer in an afflicted subject. The invention utilizes modified oligonucleotides complementary to nucleic acid encoding protein kinase A subunit RIalpha.